[1]
Nainwal, L.M. et al. 2014. Design and docking of novel series of hybrid xanthones as anti-cancer agent to target human DNA topoisomerase 2-alpha. Bangladesh Journal of Pharmacology. 9, 2 (May 2014), 208–217. DOI:https://doi.org/10.3329/bjp.v9i2.18180.